Literature DB >> 11232032

Cd40 expression in uterine tissues: a key regulator of cytokine expression by fibroblasts.

A E King1, R W Kelly, H O Critchley, A Malmstrom, M Sennstrom, R P Phipps.   

Abstract

CD40 is a cell surface receptor initially discovered on cells of the hemopoietic lineage. Its primary role on immune cells is to enhance their activation and hence their production of cytokines and immunomodulatory molecules. Recently, CD40 has also been detected on human fibroblasts. An emerging view of the fibroblast is that it is far more than a structural cell, being capable of intimate interaction with cells of the immune system. In fibroblasts from several tissues, the engagement of CD40 with its ligand (CD40L) resulted in the secretion of proinflammatory molecules such as interleukin-6 (IL-6) and IL-8. Currently, there are few data about the presence of the CD40-CD40L system in female reproductive tissues. This study investigates the expression of CD40 by human endometrium, myometrium, and cervix both in situ and in tissue explant-derived fibroblasts. CD40 was detected mainly in the perivascular region of endometrium, myometrium, and cervix. Light staining for CD40 was observed in stromal elements. Additionally, the basal epithelium of cervix expressed CD40. Fibroblastic cells derived from all three sources express low levels of CD40, and this is up-regulated with interferon-gamma treatment (500 U/mL; 72 h). When activated with interferon-gamma and CD40L, the fibroblasts secreted increased amounts of IL-6, IL-8, and MCP-1. These data suggest that the CD40-CD40L system may provide a link between the resident structural cells of these reproductive tissues and the infiltrating immune cells or activated platelets that may express CD40L. The possible interaction of CD40 with CD40L may be particularly important during events such as menstruation and cervical ripening, where up-regulation of the proinflammatory molecules IL-6 and IL-8 is viewed as critical for these processes. In addition, dysregulation of this system may be a contributory factor to problems such as menstrual dysfunction and preterm labor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232032     DOI: 10.1210/jcem.86.1.7133

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-gamma-mediated up-regulation of CD40 signalling.

Authors:  T De L Karlson; C V Whiting; P W Bland
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 2.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

3.  Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts.

Authors:  L Koumas; A E King; H O Critchley; R W Kelly; R P Phipps
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Premature labor: a state of platelet activation?

Authors:  Offer Erez; Roberto Romero; Debra Hoppensteadt; Jawed Fareed; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Nandor Gabor Than; Edi Vaisbuch; Chong Jai Kim; Jimmy Espinoza; Pooja Mittal; Neil Hamill; Chia-Ling Nhan-Chang; Moshe Mazor; Sonia Hassan
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

5.  A subset of human uterine endometrial macrophages is alternatively activated.

Authors:  Amy L Jensen; Jane Collins; Emilie P Shipman; Charles R Wira; Paul M Guyre; Patricia A Pioli
Journal:  Am J Reprod Immunol       Date:  2012-08-06       Impact factor: 3.886

6.  Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.

Authors:  Laura Koumas; Terry J Smith; Steven Feldon; Neil Blumberg; Richard P Phipps
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  MS80, a novel sulfated polysaccharide, inhibits CD40-NF-kappaB pathway via targeting RIP2.

Authors:  Xiaoguang Du; Shan Jiang; Hongchun Liu; Xianliang Xin; Jing Li; Meiyu Geng; Handong Jiang
Journal:  Mol Cell Biochem       Date:  2010-04       Impact factor: 3.396

8.  CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.

Authors:  Lawrence D True; Hui Zhang; Mingliang Ye; Chung-Ying Huang; Peter S Nelson; Priska D von Haller; Larry W Tjoelker; Jong-Seo Kim; Wei-Jun Qian; Richard D Smith; William J Ellis; Emily S Liebeskind; Alvin Y Liu
Journal:  Mod Pathol       Date:  2010-06-18       Impact factor: 7.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.